Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: SOROS who wrote (627)	5/10/1998 12:29:00 AM
From: xray	Read Replies (1) \| Respond to of 1185

Just for the record: in my experience with Jay, at the Westergaard conference which he co-hosted in NY and during his diligence visit to Nortran, he doesn't really have a propensity to exaggerate. He has a background in the pharmaceutical industry and fully understands the risks of the drug discovery and development process. Is there anything on the Westergaard site that is much unlike what the Company states in its own printed material? Is the Company really being too 'promotional'? How promotional should a company be? The experts at Nortran think they have some important findings. Outside experts have validated this.